Subtype
Anterior Pituitary Gland Neoplasm
CI-CAN-00000452Explore in graph →
Non-malignant21 active trials
- NCIt
- C45921
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000452Explore in graph →
Clinical trials
100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04106531 | Validation of a Quality of Life Metric "Prolac-10"(Prolac-10) | terminated | — | 8 | Ohio State UniversityOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT03515603 | Endocrine Outcome of Surgery for Pituitary Adenoma | terminated | N/A | 36 | University of UlmOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05338125 |
| Electrophysiology of the Human Pituitary Gland |
| terminated |
| N/A |
| 1 |
| Leiden University Medical CenterOTHER |
| 1 |
| Mar 13, 2023 |
| clinicaltrials |
| NCT00798057 | Proton Radiation Therapy for Pituitary Adenoma(PI01) | terminated | — | 16 | University of FloridaOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Dec 5, 2025source: clinicaltrials